← FDA DRUG APPROVALS

FDA NDA · NDA019897

NORPLANT

Sponsor: POPULATION COUNCIL

APPLICATION
NDA019897
TYPE
NDA
ORIGINAL APPROVAL
1990-12-10
LATEST ACTION
2001-05-21
ROUTE
IMPLANTATION
DOSAGE FORM
IMPLANT
MARKETING STATUS
Discontinued

Products

NORPLANTDiscontinued
LEVONORGESTREL 36MG/IMPLANT · IMPLANT · IMPLANTATION

Approval history

2001-05-21Manufacturing (CMC) · Supplement 11 · priorityAP
1999-08-25Manufacturing (CMC) · Supplement 10 · priorityAP
1998-12-11Manufacturing (CMC) · Supplement 9 · priorityAP
1997-10-15Manufacturing (CMC) · Supplement 6 · priorityAP
1997-10-07Manufacturing (CMC) · Supplement 7 · priorityAP
1997-09-15Manufacturing (CMC) · Supplement 8 · priorityAP
1996-07-24Manufacturing (CMC) · Supplement 5 · priorityAP
1995-03-16Manufacturing (CMC) · Supplement 4 · priorityAP
1995-01-31Manufacturing (CMC) · Supplement 3 · priorityAP
1995-01-31Manufacturing (CMC) · Supplement 2 · priorityAP
1993-11-16Manufacturing (CMC) · Supplement 1 · priorityAP
1990-12-10Type 3 - New Dosage Form · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →